Minerva Neurosciences (NERV) Net Equity Issued and Repurchased (2014 - 2026)
Minerva Neurosciences' Net Equity Issued and Repurchased came in at $10.5 million for Q2 2026, up 775.0% from the prior quarter.
Powered by 
Analysis
Minerva Neurosciences (NERV) Net Equity Issued and Repurchased (2014 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Minerva Neurosciences reported Net Equity Issued and Repurchased of $31.7 million; for FY2025, it was $80 million.
- Net Equity Issued and Repurchased carries a five-year compound annual growth rate of 42.3% (FY2020 to FY2025).
- Going back by year, Net Equity Issued and Repurchased was $20 million in FY2023.
- The Q2 2026 figure represents the highest quarterly Net Equity Issued and Repurchased since Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Minerva Neurosciences | 124.09 Mn | -188.49 Mn | - | 10.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 10.00 Mn |
| Jun 30, 2026 | 10.50 Mn |
| Mar 31, 2026 | 1.20 Mn |
| Jun 30, 2023 | 20.00 Mn |
| Sep 30, 2020 | 7.37 Mn |
| Jun 30, 2020 | 5.52 Mn |
| Mar 31, 2020 | 797,629.00 |
| Dec 31, 2019 | -1.00 |
| Mar 31, 2019 | 525,000.00 |
| Dec 31, 2018 | 165,105.00 |
| Sep 30, 2017 | 554,370.00 |
| Dec 31, 2016 | 1.24 Mn |
| Sep 30, 2016 | 9,861.00 |
| Jun 30, 2016 | 4.68 Mn |
| Mar 31, 2016 | 18.54 Mn |
| Mar 31, 2015 | 31.00 Mn |
| Dec 31, 2014 | -30,251.00 |
| Sep 30, 2014 | -3.02 Mn |
| Mar 31, 2014 | -105,417.00 |
API Access
Minerva Neurosciences Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=NERV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "NERV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=NERV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();